-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Transthyretin amyloidosis, also called ATTR amyloidosis, is a life-threatening disease characterized by the gradual accumulation of misfolded transthyretin (TTR) in tissues, mainly in the nerves and heart
NTLA-2001 is an in vivo gene editing therapeutic agent designed to treat ATTR amyloidosis by reducing the concentration of TTR in serum